TVTX
Price
$17.43
Change
-$0.49 (-2.73%)
Updated
Apr 1, 04:59 PM (EDT)
Capitalization
1.55B
29 days until earnings call
XNCR
Price
$9.69
Change
-$0.95 (-8.93%)
Updated
Apr 1 closing price
Capitalization
682.78M
36 days until earnings call
Ad is loading...

TVTX vs XNCR

Header iconTVTX vs XNCR Comparison
Open Charts TVTX vs XNCRBanner chart's image
Travere Therapeutics
Price$17.43
Change-$0.49 (-2.73%)
Volume$51.81K
Capitalization1.55B
Xencor
Price$9.69
Change-$0.95 (-8.93%)
Volume$954.82K
Capitalization682.78M
TVTX vs XNCR Comparison Chart
Loading...
TVTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XNCR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
TVTX vs. XNCR commentary
Apr 02, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is TVTX is a StrongBuy and XNCR is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
Apr 02, 2025
Stock price -- (TVTX: $17.92 vs. XNCR: $9.69)
Brand notoriety: TVTX and XNCR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: TVTX: 147% vs. XNCR: 146%
Market capitalization -- TVTX: $1.55B vs. XNCR: $682.78M
TVTX [@Biotechnology] is valued at $1.55B. XNCR’s [@Biotechnology] market capitalization is $682.78M. The market cap for tickers in the [@Biotechnology] industry ranges from $302.51B to $0. The average market capitalization across the [@Biotechnology] industry is $2.22B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

TVTX’s FA Score shows that 0 FA rating(s) are green whileXNCR’s FA Score has 1 green FA rating(s).

  • TVTX’s FA Score: 0 green, 5 red.
  • XNCR’s FA Score: 1 green, 4 red.
According to our system of comparison, TVTX is a better buy in the long-term than XNCR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

TVTX’s TA Score shows that 4 TA indicator(s) are bullish while XNCR’s TA Score has 4 bullish TA indicator(s).

  • TVTX’s TA Score: 4 bullish, 6 bearish.
  • XNCR’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, XNCR is a better buy in the short-term than TVTX.

Price Growth

TVTX (@Biotechnology) experienced а -15.83% price change this week, while XNCR (@Biotechnology) price change was -18.02% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -9.07%. For the same industry, the average monthly price growth was -13.26%, and the average quarterly price growth was -12.25%.

Reported Earning Dates

TVTX is expected to report earnings on May 01, 2025.

XNCR is expected to report earnings on May 08, 2025.

Industries' Descriptions

@Biotechnology (-9.07% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TVTX($1.55B) has a higher market cap than XNCR($683M). TVTX YTD gains are higher at: 2.870 vs. XNCR (-57.833). XNCR has higher annual earnings (EBITDA): -186.17M vs. TVTX (-265.77M). XNCR has more cash in the bank: 498M vs. TVTX (371M). XNCR has less debt than TVTX: XNCR (232M) vs TVTX (402M). TVTX has higher revenues than XNCR: TVTX (233M) vs XNCR (110M).
TVTXXNCRTVTX / XNCR
Capitalization1.55B683M227%
EBITDA-265.77M-186.17M143%
Gain YTD2.870-57.833-5%
P/E RatioN/AN/A-
Revenue233M110M212%
Total Cash371M498M74%
Total Debt402M232M173%
FUNDAMENTALS RATINGS
TVTX vs XNCR: Fundamental Ratings
TVTX
XNCR
OUTLOOK RATING
1..100
5552
VALUATION
overvalued / fair valued / undervalued
1..100
86
Overvalued
79
Overvalued
PROFIT vs RISK RATING
1..100
89100
SMR RATING
1..100
10097
PRICE GROWTH RATING
1..100
3793
P/E GROWTH RATING
1..100
394
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

XNCR's Valuation (79) in the Biotechnology industry is in the same range as TVTX (86). This means that XNCR’s stock grew similarly to TVTX’s over the last 12 months.

TVTX's Profit vs Risk Rating (89) in the Biotechnology industry is in the same range as XNCR (100). This means that TVTX’s stock grew similarly to XNCR’s over the last 12 months.

XNCR's SMR Rating (97) in the Biotechnology industry is in the same range as TVTX (100). This means that XNCR’s stock grew similarly to TVTX’s over the last 12 months.

TVTX's Price Growth Rating (37) in the Biotechnology industry is somewhat better than the same rating for XNCR (93). This means that TVTX’s stock grew somewhat faster than XNCR’s over the last 12 months.

XNCR's P/E Growth Rating (4) in the Biotechnology industry is somewhat better than the same rating for TVTX (39). This means that XNCR’s stock grew somewhat faster than TVTX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
TVTXXNCR
RSI
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
71%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
74%
Momentum
ODDS (%)
Bearish Trend 2 days ago
86%
N/A
MACD
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
78%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
82%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
80%
Bearish Trend 2 days ago
82%
Advances
ODDS (%)
Bullish Trend 13 days ago
80%
Bullish Trend 13 days ago
72%
Declines
ODDS (%)
Bearish Trend 2 days ago
78%
Bearish Trend 2 days ago
79%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
61%
Aroon
ODDS (%)
Bearish Trend 2 days ago
80%
Bearish Trend 2 days ago
77%
View a ticker or compare two or three
Ad is loading...
TVTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XNCR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
EIUTX15.66N/A
N/A
Eaton Vance Dividend Builder I
JDBRX44.11N/A
N/A
Janus Henderson Balanced R
ATGYX40.10N/A
N/A
Cantor Fitzgerald Equity Opp Inst
DMCRX11.59N/A
N/A
Driehaus Micro Cap Growth
GAOZX20.23-0.01
-0.03%
JPMorgan Global Allocation R6